WASHINGTON, D.C. 20549
(AMENDMENT NO. 29)
If the filing person has previously filed
a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule
because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following
box. ¨
NOTE: Schedules filed in paper format shall
include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies
are to be sent.
CUSIP NO. 141743104
|
13D
|
Page 2 of 21
|
(1) The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment
containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder
of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act
of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all
other provisions of the Act (however, see the Notes).
CUSIP NO. 141743104
|
13D
|
Page 3 of 21
|
(1)
|
NAME OF REPORTING PERSON
|
|
|
HealthCor Management, L.P.
|
|
(2)
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
|
|
|
(a) ¨
|
|
|
(b) x
|
(3)
|
SEC USE ONLY
|
|
(4)
|
SOURCE OF FUNDS
|
|
|
WC
|
|
(5)
|
CHECK
BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
|
¨
|
(6)
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
Delaware
|
|
|
(7)
|
SOLE VOTING POWER
|
|
NUMBER OF
|
|
0
|
|
SHARES
|
(8)
|
SHARED VOTING POWER
|
|
BENEFICIALLY
|
|
16,592,478
|
|
OWNED BY
|
(9)
|
SOLE DISPOSITIVE POWER
|
|
EACH
|
|
0
|
|
REPORTING
|
(10)
|
SHARED DISPOSITIVE POWER
|
|
PERSON WITH
|
|
16,592,478
|
|
(11)
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
16,592,478
|
|
(12)
|
CHECK BOX IF THE
AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
|
¨
|
(13)
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
|
|
|
10.6%
|
|
(14)
|
TYPE OF REPORTING PERSON
|
|
|
PN
|
|
CUSIP NO. 141743104
|
13D
|
Page 4 of 21
|
(1)
|
NAME OF REPORTING PERSON
|
|
|
HealthCor Associates, LLC
|
|
(2)
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
|
|
|
(a) ¨
|
|
|
(b) x
|
(3)
|
SEC USE ONLY
|
|
(4)
|
SOURCE OF FUNDS
|
|
|
AF
|
|
(5)
|
CHECK
BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
|
¨
|
(6)
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
Delaware
|
|
|
(7)
|
SOLE VOTING POWER
|
|
NUMBER OF
|
|
0
|
|
SHARES
|
(8)
|
SHARED VOTING POWER
|
|
BENEFICIALLY
|
|
16,592,478
|
|
OWNED BY
|
(9)
|
SOLE DISPOSITIVE POWER
|
|
EACH
|
|
0
|
|
REPORTING
|
(10)
|
SHARED DISPOSITIVE POWER
|
|
PERSON WITH
|
|
16,592,478
|
|
(11)
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
16,592,478
|
|
(12)
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
|
¨
|
(13)
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
|
|
|
10.6%
|
|
(14)
|
TYPE OF REPORTING PERSON
|
|
|
OO- limited liability company
|
|
CUSIP NO. 141743104
|
13D
|
Page 5 of 21
|
(1)
|
NAME OF REPORTING PERSON
|
|
|
HealthCor Hybrid Offshore Master Fund, L.P.
|
|
(2)
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
|
|
|
(a) ¨
|
|
|
(b) x
|
(3)
|
SEC USE ONLY
|
|
(4)
|
SOURCE OF FUNDS
|
|
|
AF
|
|
(5)
|
CHECK BOX IF
DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
|
¨
|
(6)
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
Cayman
Islands
|
|
|
(7)
|
SOLE VOTING POWER
|
|
NUMBER OF
|
|
0
|
|
SHARES
|
(8)
|
SHARED VOTING POWER
|
|
BENEFICIALLY
|
|
16,592,478
|
|
OWNED BY
|
(9)
|
SOLE DISPOSITIVE POWER
|
|
EACH
|
|
0
|
|
REPORTING
|
(10)
|
SHARED DISPOSITIVE POWER
|
|
PERSON WITH
|
|
16,592,478
|
|
(11)
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
16,592,478
|
|
(12)
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
|
¨
|
(13)
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
|
|
|
10.6%
|
|
(14)
|
TYPE OF REPORTING PERSON
|
|
|
PN
|
|
CUSIP NO. 141743104
|
13D
|
Page 6 of 21
|
(1)
|
NAME OF REPORTING PERSON
|
|
|
HealthCor Hybrid Offshore GP, LLC
|
|
(2)
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
|
|
|
(a) ¨
|
|
|
(b) x
|
(3)
|
SEC USE ONLY
|
|
(4)
|
SOURCE OF FUNDS
|
|
|
AF
|
|
(5)
|
CHECK
BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
|
¨
|
(6)
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
Delaware
|
|
|
(7)
|
SOLE VOTING POWER
|
|
NUMBER OF
|
|
0
|
|
SHARES
|
(8)
|
SHARED VOTING POWER
|
|
BENEFICIALLY
|
|
16,592,478
|
|
OWNED BY
|
(9)
|
SOLE DISPOSITIVE POWER
|
|
EACH
|
|
0
|
|
REPORTING
|
(10)
|
SHARED DISPOSITIVE POWER
|
|
PERSON WITH
|
|
16,592,478
|
|
(11)
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
16,592,478
|
|
(12)
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
|
¨
|
(13)
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
|
|
|
10.6%
|
|
(14)
|
TYPE OF REPORTING PERSON
|
|
|
OO-limited liability company
|
|
CUSIP NO. 141743104
|
13D
|
Page 7 of 21
|
(1)
|
NAME OF REPORTING PERSON
|
|
|
HealthCor Group, LLC
|
|
(2)
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
|
|
|
(a) ¨
|
|
|
(b) x
|
(3)
|
SEC USE ONLY
|
|
(4)
|
SOURCE OF FUNDS
|
|
|
AF
|
|
(5)
|
CHECK
BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
|
¨
|
(6)
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
Delaware
|
|
|
(7)
|
SOLE VOTING POWER
|
|
NUMBER OF
|
|
0
|
|
SHARES
|
(8)
|
SHARED VOTING POWER
|
|
BENEFICIALLY
|
|
16,592,478
|
|
OWNED BY
|
(9)
|
SOLE DISPOSITIVE POWER
|
|
EACH
|
|
0
|
|
REPORTING
|
(10)
|
SHARED DISPOSITIVE POWER
|
|
PERSON WITH
|
|
16,592,478
|
|
(11)
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
16,592,478
|
|
(12)
|
CHECK BOX IF THE
AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
|
¨
|
(13)
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
|
|
|
10.6%
|
|
(14)
|
TYPE OF REPORTING PERSON
|
|
|
OO-limited liability company
|
|
CUSIP NO. 141743104
|
13D
|
Page 8 of 21
|
(1)
|
NAME OF REPORTING PERSON
|
|
|
HealthCor Partners Management, L.P.
|
|
(2)
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
|
|
|
(a) ¨
|
|
|
(b) x
|
(3)
|
SEC USE ONLY
|
|
(4)
|
SOURCE OF FUNDS
|
|
|
WC
|
|
(5)
|
CHECK
BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
|
¨
|
(6)
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
Delaware
|
|
|
(7)
|
SOLE VOTING POWER
|
|
NUMBER OF
|
|
0
|
|
SHARES
|
(8)
|
SHARED VOTING POWER
|
|
BENEFICIALLY
|
|
18,684,177
|
|
OWNED BY
|
(9)
|
SOLE DISPOSITIVE POWER
|
|
EACH
|
|
0
|
|
REPORTING
|
(10)
|
SHARED DISPOSITIVE POWER
|
|
PERSON WITH
|
|
18,684,177
|
|
(11)
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
18,684,177
|
|
(12)
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
|
¨
|
(13)
|
PERCENT OF CLASS REPRESENTED
|
|
|
BY AMOUNT IN ROW (11)
|
|
|
11.8%
|
|
(14)
|
TYPE OF REPORTING PERSON
|
|
|
PN
|
|
CUSIP NO. 141743104
|
13D
|
Page 9 of 21
|
(1)
|
NAME OF REPORTING PERSON
|
|
|
HealthCor Partners Management GP, LLC
|
|
(2)
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
|
|
|
(a) ¨
|
|
|
(b) x
|
(3)
|
SEC USE ONLY
|
|
(4)
|
SOURCE OF FUNDS
|
|
|
AF
|
|
(5)
|
CHECK
BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
|
¨
|
(6)
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
Delaware
|
|
|
(7)
|
SOLE VOTING POWER
|
|
NUMBER OF
|
|
0
|
|
SHARES
|
(8)
|
SHARED VOTING POWER
|
|
BENEFICIALLY
|
|
18,684,177
|
|
OWNED BY
|
(9)
|
SOLE DISPOSITIVE POWER
|
|
EACH
|
|
0
|
|
REPORTING
|
(10)
|
SHARED DISPOSITIVE POWER
|
|
PERSON WITH
|
|
18,684,177
|
|
(11)
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
18,684,177
|
|
(12)
|
CHECK BOX IF THE
AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
|
¨
|
(13)
|
PERCENT OF CLASS
REPRESENTED BY AMOUNT IN ROW (11)
|
|
|
11.8%
|
|
(14)
|
TYPE OF REPORTING PERSON
|
|
|
OO-
limited liability company
|
|
CUSIP NO. 141743104
|
13D
|
Page 10 of 21
|
(1)
|
NAME OF REPORTING PERSON
|
|
|
HealthCor Partners Fund, L.P.
|
|
(2)
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
|
|
|
(a) ¨
|
|
|
(b) x
|
(3)
|
SEC USE ONLY
|
|
(4)
|
SOURCE OF FUNDS
|
|
|
AF
|
|
(5)
|
CHECK
BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
|
¨
|
(6)
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
Delaware
|
|
|
(7)
|
SOLE VOTING POWER
|
|
NUMBER OF
|
|
0
|
|
SHARES
|
(8)
|
SHARED VOTING POWER
|
|
BENEFICIALLY
|
|
18,684,177
|
|
OWNED BY
|
(9)
|
SOLE DISPOSITIVE POWER
|
|
EACH
|
|
0
|
|
REPORTING
|
(10)
|
SHARED DISPOSITIVE POWER
|
|
PERSON WITH
|
|
18,684,177
|
|
(11)
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
18,684,177
|
|
(12)
|
CHECK BOX IF THE
AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
|
¨
|
(13)
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
|
|
|
11.8%
|
|
(14)
|
TYPE OF REPORTING PERSON
|
|
|
PN
|
|
CUSIP NO. 141743104
|
13D
|
Page 11 of 21
|
(1)
|
NAME OF REPORTING PERSON
|
|
|
HealthCor Partners L.P.
|
|
(2)
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
|
|
|
(a) ¨
|
|
|
(b) x
|
(3)
|
SEC USE ONLY
|
|
(4)
|
SOURCE OF FUNDS
|
|
|
AF
|
|
(5)
|
CHECK
BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
|
¨
|
(6)
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
Delaware
|
|
|
(7)
|
SOLE VOTING POWER
|
|
NUMBER OF
|
|
0
|
|
SHARES
|
(8)
|
SHARED VOTING POWER
|
|
BENEFICIALLY
|
|
18,684,177
|
|
OWNED BY
|
(9)
|
SOLE DISPOSITIVE POWER
|
|
EACH
|
|
0
|
|
REPORTING
|
(10)
|
SHARED DISPOSITIVE POWER
|
|
PERSON WITH
|
|
18,684,177
|
|
(11)
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
18,684,177
|
|
(12)
|
CHECK BOX IF THE
AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
|
¨
|
(13)
|
PERCENT OF CLASS
REPRESENTED BY AMOUNT IN ROW (11)
|
|
|
11.8%
|
|
(14)
|
TYPE OF REPORTING PERSON
|
|
|
PN
|
|
CUSIP NO. 141743104
|
13D
|
Page 12 of 21
|
(1)
|
NAME OF REPORTING PERSON
|
|
|
HealthCor Partners GP, LLC
|
|
(2)
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
|
|
|
(a) ¨
|
|
|
(b) x
|
(3)
|
SEC USE ONLY
|
|
(4)
|
SOURCE OF FUNDS
|
|
|
AF
|
|
(5)
|
CHECK
BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
|
¨
|
(6)
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
Delaware
|
|
|
(7)
|
SOLE VOTING POWER
|
|
NUMBER OF
|
|
0
|
|
SHARES
|
(8)
|
SHARED VOTING POWER
|
|
BENEFICIALLY
|
|
18,684,177
|
|
OWNED BY
|
(9)
|
SOLE DISPOSITIVE POWER
|
|
EACH
|
|
0
|
|
REPORTING
|
(10)
|
SHARED DISPOSITIVE POWER
|
|
PERSON WITH
|
|
18,684,177
|
|
(11)
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
18,684,177
|
|
(12)
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
|
¨
|
(13)
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
|
|
|
11.8%
|
|
(14)
|
TYPE OF REPORTING PERSON
|
|
|
OO- limited liability company
|
|
CUSIP NO. 141743104
|
13D
|
Page 13 of 21
|
(1)
|
NAME OF REPORTING PERSON
|
|
|
Jeffrey C. Lightcap
|
|
(2)
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
|
|
|
(a) ¨
|
|
|
(b) x
|
(3)
|
SEC USE ONLY
|
|
(4)
|
SOURCE OF FUNDS
|
|
|
AF, PF
|
|
(5)
|
CHECK BOX IF
DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
|
¨
|
(6)
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
United
States
|
|
|
(7)
|
SOLE VOTING POWER
|
|
NUMBER OF
|
|
27,706,724
|
|
SHARES
|
(8)
|
SHARED VOTING POWER
|
|
BENEFICIALLY
|
|
18,684,177
|
|
OWNED BY
|
(9)
|
SOLE DISPOSITIVE POWER
|
|
EACH
|
|
27,706,724
|
|
REPORTING
|
(10)
|
SHARED DISPOSITIVE POWER
|
|
PERSON WITH
|
|
18,684,177
|
|
(11)
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
46,390,901
|
|
(12)
|
CHECK BOX IF THE
AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
|
¨
|
(13)
|
PERCENT OF CLASS
REPRESENTED BY AMOUNT IN ROW (11)
|
|
|
25.0%
|
|
(14)
|
TYPE OF REPORTING PERSON
|
|
|
IN
|
|
CUSIP NO. 141743104
|
13D
|
Page 14 of 21
|
(1)
|
NAME OF REPORTING PERSON
|
|
|
Arthur Cohen
|
|
(2)
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
|
|
|
(a) ¨
|
|
|
(b) x
|
(3)
|
SEC USE ONLY
|
|
(4)
|
SOURCE OF FUNDS
|
|
|
AF, PF
|
|
(5)
|
CHECK
BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
|
¨
|
(6)
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
United
States
|
|
|
(7)
|
SOLE VOTING POWER
|
|
NUMBER OF
|
|
3,432,714
|
|
SHARES
|
(8)
|
SHARED VOTING POWER
|
|
BENEFICIALLY
|
|
35,276,655
|
|
OWNED BY
|
(9)
|
SOLE DISPOSITIVE POWER
|
|
EACH
|
|
3,432,714
|
|
REPORTING
|
(10)
|
SHARED DISPOSITIVE POWER
|
|
PERSON WITH
|
|
35,276,655
|
|
(11)
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
38,709,369
|
|
(12)
|
CHECK BOX IF THE
AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
|
¨
|
(13)
|
PERCENT OF CLASS
REPRESENTED BY AMOUNT IN ROW (11)
|
|
|
21.7%
|
|
(14)
|
TYPE OF REPORTING PERSON
|
|
|
IN
|
|
CUSIP NO. 141743104
|
13D
|
Page 15 of 21
|
(1)
|
NAME OF REPORTING PERSON
|
|
|
Joseph Healey
|
|
(2)
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
|
|
|
(a) ¨
|
|
|
(b) x
|
(3)
|
SEC USE ONLY
|
|
(4)
|
SOURCE OF FUNDS
|
|
|
AF, PF
|
|
(5)
|
CHECK BOX IF
DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
|
¨
|
(6)
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
United
States
|
|
|
(7)
|
SOLE VOTING POWER
|
|
NUMBER OF
|
|
2,529,740
|
|
SHARES
|
(8)
|
SHARED VOTING POWER
|
|
BENEFICIALLY
|
|
35,276,655
|
|
OWNED BY
|
(9)
|
SOLE DISPOSITIVE POWER
|
|
EACH
|
|
2,529,740
|
|
REPORTING
|
(10)
|
SHARED DISPOSITIVE POWER
|
|
PERSON WITH
|
|
35,276,655
|
|
(11)
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
37,806,395
|
|
(12)
|
CHECK BOX IF THE
AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
|
¨
|
(13)
|
PERCENT OF CLASS
REPRESENTED BY AMOUNT IN ROW (11)
|
|
|
21.3%
|
|
(14)
|
TYPE OF REPORTING PERSON
|
|
|
IN
|
|
CUSIP NO. 141743104
|
13D
|
Page 16 of 21
|
This Amendment No. 29 to Schedule 13D (the
“Amendment”) amends and supplements the beneficial ownership statement on Schedule 13D originally filed with the
Securities and Exchange Commission on May 2, 2011, as amended by Amendment No. 1 filed October 3, 2011, Amendment No. 2 filed
January 3, 2012, Amendment No. 3 filed February 2, 2012, Amendment No. 4 filed October 2, 2012, Amendment No. 5 filed April
5, 2013, Amendment No. 6 filed October 2, 2013, Amendment No. 7 filed January 3, 2014, Amendment No. 8 filed January 21,
2014, Amendment No. 9 filed July 1, 2014, Amendment No. 10 filed January 6, 2015, Amendment No. 11 filed February 20, 2015,
Amendment No. 12 filed April 12, 2015, Amendment No. 13 filed July 6, 2015, Amendment No. 14 filed October 2, 2015, Amendment
No. 15 filed January 4, 2016, Amendment No. 16 filed April 6, 2016, Amendment No. 17 filed July 1, 2016, Amendment No.
18 filed October 3, 2016, Amendment No. 19 filed January 3, 2017, Amendment No. 20 filed April 3, 2017, Amendment No. 21
filed July 5, 2017, Amendment No. 22 filed October 2, 2017, Amendment No. 23 filed January 3, 2018, Amendment No. 24 filed
February 28, 2018, Amendment No. 25 filed July 17, 2018, Amendment No. 26 filed January 3, 2019, Amendment No. 27 filed May
17, 2019 and Amendment No. 28 filed January 2, 2020 (collectively, the “Original Statement”). The persons filing
this Amendment are HealthCor Management, L.P., HealthCor Associates, LLC, HealthCor Hybrid Offshore Master Fund, L.P.,
HealthCor Hybrid Offshore GP, LLC, HealthCor Group, LLC, HealthCor Partners Management, L.P., HealthCor Partners Management
GP, LLC, HealthCor Partners Fund, L.P., HealthCor Partners, L.P., HealthCor Partners GP, LLC, Jeffrey C. Lightcap, Joseph
Healey and Arthur Cohen. The Original Statement, as amended by this Amendment (the “Statement”), relates to the
shares of Common Stock of CareView Communications, Inc., par value $0.001 (the “Common Stock”).
Capitalized terms used herein but not defined shall have the
meanings ascribed to them in the Original Statement. This Amendment amends the Original Statement as specifically set forth herein.
Except as set forth below, all previous Items in the Original Statement remain unchanged.
The Amendment is being filed for the purpose of reflecting the
acquisition of an additional Note by one of the Reporting Persons pursuant to the Thirteenth Amendment (as defined in, and as described
in, Item 6 below) on February 6, 2020. Amounts reported in this Amendment also include interest payable in kind on March 31, 2020
with respect to the 2014 Notes, the 2015 Notes, the 2018 Notes, the Tenth Amendment Notes, the Twelfth Amendment Notes and the
Thirteenth Amendment Notes (as defined herein), because the scheduled interest payment date falls within 60 days of the date of
this Amendment.
Item 5. Interest in
Securities of the Issuer
Item 5 is hereby amended and restated in its entirety as follows:
(a) Collectively, the Reporting Persons beneficially own an aggregate
of 68,945,833 shares of Common Stock, representing (i) 10,185,313 shares of Common Stock that may be acquired upon conversion of
the Thirteenth Amendment Notes (as defined in Item 6 below, and including interest payable in kind on March 31, 2020), (ii) 1,856,696
shares of Common Stock that may be acquired upon conversion of the Twelfth Amendment Notes (including interest paid or payable
in kind through March 31, 2020), (iii) 6,175,301 shares of Common Stock that may be acquired upon conversion of the Tenth Amendment
Notes (including interest paid or payable in kind through March 31, 2020), (iv) 6,475,551 shares of Common Stock that may be acquired
upon conversion of the 2018 Notes (including interest paid or payable in kind through March 31, 2020), (v) 11,213,640 shares of
Common Stock that may be acquired upon conversion of the 2015 Notes (including interest paid or payable in kind through March 31,
2020), (vi) 26,060,423 shares of Common Stock that may be acquired upon conversion of the 2014 Notes (including interest paid or
payable in kind through March 31, 2020), (vii) 4,000,000 shares of Common Stock that may be acquired upon exercise of the 2014
Warrants, (viii) 1,916,409 shares of Common Stock that may be acquired upon exercise of the 2015 Warrants, (ix) 1,000,000 shares
of Common Stock that may be acquired upon exercise of the Sixth Amendment Warrants and (x) 62,500 shares of Common Stock that may
be acquired upon exercise of the 2018 Warrants (the 2014 Warrants, the 2015 Warrants, the Sixth Amendment Warrants and the 2018
Warrants together, the "Warrants"). This aggregate amount represents approximately 33.1% of the Issuer's outstanding
common stock, based upon 139,380,748 shares outstanding as of November 14, 2019, as reported in the Issuer's most recent Quarterly
Report on Form 10-Q, and gives effect to the conversion of all 2014 Notes, 2015 Notes, 2018 Notes, Tenth Amendment Notes, Twelfth
Amendment Notes and Thirteenth Amendment Notes held by the Reporting Persons into Common Stock and the exercise of all Warrants
held by the Reporting Persons.
CUSIP NO. 141743104
|
13D
|
Page 17 of 21
|
Of the amount beneficially owned by the Reporting Persons:
(i) HCP Fund is the beneficial owner of (A) 3,600,848 shares of
Common Stock underlying the current principal amount of the 2015 Note issued to it (including interest paid or payable in kind
through March 31, 2020), (B) 12,138,945 shares of Common Stock underlying the current principal amount of the 2014 Note issued
to it (including interest paid or payable in kind through March 31, 2020), (C) 465,800 shares of Common Stock that it has a right
to acquire upon exercise of its Sixth Amendment Warrant, (D) 615,384 shares of Common Stock that it has a right to acquire upon
exercise of its 2015 Warrant, and (E) 1,863,200 shares of Common Stock that it has a right to acquire upon exercise of its 2014
Warrant;
(ii) By virtue of their relationship to HCP Fund,
described in more detail under Item 2 of this Statement, each of HealthCor Partners, L.P., HCPGP, HealthCor Partners Management,
L.P., and HCPMGP may be deemed to share beneficial ownership with HCP Fund of the shares of Common Stock beneficially owned by
the HCP Fund;
(iii) Hybrid Fund is the beneficial owner of (A) 13,921,478 shares
of Common Stock underlying the current principal amount of the 2014 Note issued to it (including interest paid or payable in kind
through March 31, 2020), (B) 534,200 shares of Common Stock that it has a right to acquire upon exercise of its Sixth Amendment
Warrant, and (C) 2,136,800 shares of Common Stock that it has a right to acquire upon exercise of its 2014 Warrant;
(iv) By virtue of their relationship to Hybrid Fund,
described in more detail under Item 2 of this Statement, each of Offshore GP, Group, HealthCor Management, L.P., and Associates
may be deemed to share beneficial ownership with Hybrid Fund of the shares of Common Stock beneficially owned by the Hybrid Fund;
(v) By virtue of his relationship to HCP Fund, Mr.
Lightcap may be deemed to share beneficial ownership of the shares of Common Stock beneficially owned by HCP Fund. In addition,
Mr. Lightcap is the beneficial owner of (A) 10,185,313 shares of Common Stock underlying the principal amount of the Thirteenth
Amendment Note purchased by him under the Thirteenth Amendment (including interest payable in kind through March 31, 2020), (B)
1,856,696 shares of Common Stock underlying the principal amount of the Twelfth Amendment Note purchased by him under the Twelfth
Amendment (including interest paid or payable in kind through March 31, 2020); (C) 6,175,301 shares of Common Stock underlying
the current principal amount of the Tenth Amendment Note purchased by him pursuant to the Tenth Amendment (including interest
paid or payable in kind through March 31, 2020); (D) 6,475,551 shares of Common Stock underlying the current principal amount
of the 2018 Note purchased by him under the Eighth Amendment (including interest paid or payable in kind through March 31, 2020),
(E) 2,520,594 shares of Common Stock underlying the current principal amount of the 2015 Note purchased by him under the Fifth
Amendment (including interest paid or payable in kind through March 31, 2020), (F) 62,500 shares of Common Stock that he has a
right to acquire upon exercise of his 2018 Warrant and (G) 430,769 shares of Common Stock that he has a right to acquire upon
exercise of his 2015 Warrant;
CUSIP NO. 141743104
|
13D
|
Page 18 of 21
|
(vi) By virtue of his relationship to HCP Fund and Hybrid Fund,
Mr. Cohen may be deemed to share beneficial ownership of the shares of Common Stock beneficially owned by each of the Funds. In
addition, Mr. Cohen is the beneficial owner of (A) 2,931,689 shares of Common Stock underlying the current principal amount of
the 2015 Note purchased by him under the Fifth Amendment (including interest paid or payable in kind through March 31, 2020) and
(B) 501,025 shares of Common Stock that he has a right to acquire upon exercise of his 2015 Warrant; and
(vii) By virtue of his relationship to HCP Fund and Hybrid Fund, Mr.
Healey may be deemed to share beneficial ownership of the shares of Common Stock beneficially owned by each of the Funds. In addition,
Mr. Healey is the beneficial owner of (A) 2,160,509 shares of Common Stock underlying the current principal amount of the 2015
Note purchased by him under the Fifth Amendment (including interest paid or payable in kind through March 31, 2020) and (B) 369,231
shares of Common Stock that he has a right to acquire upon exercise of his 2015 Warrant.
The filing of this Statement shall not be construed
as an admission that any of the Reporting Persons is, for the purposes of Section 13(d) or 13(g) of the Securities Exchange Act
of 1934, as amended, the beneficial owner of any of the shares of Common Stock owned by the Funds or any other Reporting Person.
Pursuant to Rule 13d-4, each of the Reporting Persons disclaims such beneficial ownership.
(b) The information
in Items 7 through 10 of each cover page to this Statement is incorporated by reference into this Item 5(b).
(c) Except as set forth in Item 6 below, the Reporting Persons
have effected no transactions relating to the Common Stock since their most recent amendment to the Original Statement.
(d) - (e) Inapplicable.
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS
WITH RESPECT TO SECURITIES OF THE ISSUER
Item 6 is hereby amended and supplemented as follows:
On February 6, 2020, the Issuer, Mr. Lightcap and the Majority
Holders (for purposes of approving the transactions) entered into the Thirteenth Amendment to the Note and Warrant Purchase Agreement
(the "Thirteenth Amendment"), pursuant to which the Issuer sold and issued to Mr. Lightcap, for a purchase price of $100,000
in cash, additional notes in principal amount of $100,000, with a conversion price of $0.01 per share (subject to adjustment as
described therein) and a maturity date of February 5, 2030 (the "Thirteenth Amendment Note"). For purposes of this Statement,
references to "Notes" shall include the Thirteenth Amendment Note.
CUSIP NO. 141743104
|
13D
|
Page 19 of 21
|
Item 7. MATERIAL TO BE FILED AS EXHIBITS
Item 7 is hereby supplemented as follows:
Exhibit No.
|
Description
|
|
|
56
|
Thirteenth Amendment to Note and Warrant Purchase Agreement.
|
|
|
57
|
Thirteenth Amendment Note.
|
CUSIP NO. 141743104
|
13D
|
Page 20 of 21
|
SIGNATURES
After reasonable inquiry and to the best of
my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
February 10, 2020
|
HEALTHCOR MANAGEMENT, L.P.
|
|
|
|
|
|
|
By: HealthCor Associates, LLC, its general partner
|
|
|
|
|
|
|
By:
|
/s/ Anabelle Perez Gray
|
|
|
Name: Anabelle Perez Gray
|
|
|
Title: General Counsel
|
|
HEALTHCOR HYBRID OFFSHORE GP, LLC, for itself and as general partner on behalf of HEALTHCOR HYBRID OFFSHORE MASTER FUND, L.P.
|
|
|
|
|
|
|
By: HealthCor Group, LLC, its general partner
|
|
|
|
|
|
|
By:
|
/s/ Anabelle Perez Gray
|
|
|
Name: Anabelle Perez Gray
|
|
|
Title: General Counsel
|
|
|
|
|
|
HEALTHCOR ASSOCIATES, LLC
|
|
|
|
|
|
|
By:
|
/s/ Anabelle Perez Gray
|
|
|
Name: Anabelle Perez Gray
|
|
|
Title: General Counsel
|
|
|
|
|
|
HEALTHCOR GROUP, LLC
|
|
|
|
|
|
|
By:
|
/s/ Anabelle Perez Gray
|
|
|
Name: Anabelle Perez Gray
|
|
|
Title: General Counsel
|
|
|
|
|
|
HEALTHCOR PARTNERS MANAGEMENT, L.P.
|
|
|
|
|
|
|
By: HealthCor Partners Management GP, LLC, its general partner
|
|
|
|
|
|
|
By:
|
/s/ Jeffrey C. Lightcap
|
|
|
Name: Jeffrey C. Lightcap
|
|
|
Title: Member
|
CUSIP NO. 141743104
|
13D
|
Page 21 of 21
|
|
HEALTHCOR PARTNERS MANAGEMENT GP, LLC
|
|
|
|
|
|
|
By:
|
/s/ Jeffrey C. Lightcap
|
|
|
Name: Jeffrey C. Lightcap
|
|
|
Title: Member
|
|
|
|
|
|
HEALTHCOR PARTNERS L.P., for itself and as
general partner on behalf of HEALTHCOR PARTNERS FUND, L.P.
|
|
|
|
|
|
|
By: HealthCor Partners GP, LLC, its general partner
|
|
|
|
|
|
|
By:
|
/s/ Jeffrey C. Lightcap
|
|
|
Name: Jeffrey C. Lightcap
|
|
|
Title: Member
|
|
|
|
|
|
HEALTHCOR PARTNERS GP, LLC
|
|
|
|
|
|
|
By:
|
/s/ Jeffrey C. Lightcap
|
|
|
Name: Jeffrey C. Lightcap
|
|
|
Title: Member
|
|
|
|
|
|
JEFFREY C. LIGHTCAP, Individually
|
|
|
|
|
|
|
/s/ Jeffrey C. Lightcap
|
|
|
|
|
|
JOSEPH HEALEY, Individually
|
|
|
|
|
|
|
/s/ Joseph Healey
|
|
|
|
|
|
ARTHUR COHEN, Individually
|
|
|
|
|
|
|
/s/ Arthur Cohen
|